Testing effectiveness (Phase 2)Study completedNCT03291847
What this trial is testing
Maternal Buprenorphine-naloxone Treatment and the Infant
Who this might be right for
Maternal Opioid Use DisorderOpioid Exposed Infant
Johns Hopkins University 42
Showing 6 of 6 results